Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pacific Biosciences of California Inc. sell StockNews.com

Start price
€1.39
18.04.24 / 50%
Target price
-
18.04.25
Performance (%)
11.56%
Price
€1.55
30.04.24
Summary
This prediction is currently active. The SELL prediction by StockNews_com currently has a performance of 11.56%. This prediction currently runs until 18.04.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this prediction
Performance without dividends (%)
Name 1w
Pacific Biosciences of California Inc. 13.284%
iShares Core DAX® -1.370%
iShares Nasdaq 100 0.172%
iShares Nikkei 225® -0.801%
iShares S&P 500 -0.369%

Comments by StockNews_com for this prediction

In the thread Pacific Biosciences of California Inc. diskutieren

Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for PACB provided by MarketBeat

Stopped prediction by StockNews_com for Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€3.86
12.03.24
-
12.03.25
-59.86%
30.04.24

Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€5.85
13.01.24
-
13.01.25
-73.50%
30.04.24

Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€9.37
29.12.23
-
29.12.24
-83.44%
30.04.24